As already announced on July 5th 2007, the privately owned Pentapharm Holding Ltd. and DSM Nutritional Products Ltd. have signed an agreement on the sale of 100% of the Pentapharm´s shares to DSM. This deal fits well into DSM’s Vision 2010 strategy to focus on accelerating and innovative growth and also allows Pentapharm to sustain and exceed its defined growth targets.

Today we can announce the legal closing of the deal. Caspar Stürm, Pentapharm’s CEO for almost 25 years, handed over the ownership of the company to DSM with the confidence to have secured the future of the Pentapharm tradition. Dr. Ute Schick, Director of DSM Nutritional Products New Business Development – Personal Care will be the successor of Mr. Stürm.

The official signing of the contracts also represents the first major milestone in the joint future and officially starts the cooperative integration activities. It is the clear goal to create the global leading supplier of cosmetic active ingredients by combining DSM’s excellent capabilities in terms of claim substantiation, test design and regulatory environment, with Pentapharm’s track-record in positioning and introduction of innovative products.

DSM’s strategy aims at creating value with this acquisition by inter-linking the two company’s complementary strengths. Therefore the integration will be based on best knowledge in both companies to provide the most beneficial outcome.

Since the joint integration planning has just started, no immediate changes are to be expected for any of the internal or external stakeholders. All Pentapharm contact persons for orders, supply and other requests will remain unchanged for the time being and be at customers` disposal with the same high level of service standard they are used to. Some visions regarding the future of the combined entities have already been defined.

With the new and potent owner DSM in the back, Pentapharm is looking forward to anoutstanding and long-lasting relationship with existing and new partners.

About DSM Nutritional Products

DSM Nutritional Products is the world's leading supplier of vitamins, carotenoids and other fine chemicals to the feed, food, pharmaceutical and personal care industries. The business has sales of about EUR 2 billion and a long tradition as a pioneer in the discovery of new products, new formulations and attractive applications for all industry segments. For further company information please visit www.dsmnutritionalproducts.com

About DSM

DSM is active worldwide in nutritional and pharma ingredients, performance materials and industrial chemicals. The company develops, produces and sells innovative products and services that help improve the quality of life. DSM’s products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics (E&E). DSM’s strategy, named Vision 2010 – Building on Strengths, focuses on accelerating profitable and innovative growth of the company’s specialties portfolio. The key drivers of this strategy are market-driven growth and innovation plus an increased presence in emerging economies. The group has annual sales of over €8 billion and employs some 22,000 people worldwide. DSM ranks among the global leaders in many of its fields. The company is headquartered in the Netherlands, with locations in Europe, Asia, Africa, Australia and the Americas. More information about DSM can be found at www.dsm.com

www.pentapharm.com

For more information:
DSM Nutritional Products
Charlotte Frederiksen

Tel. +41 (0) 61 688 85 14
Fax +41 (0) 61 687 37 16

E-mail: charlotte.frederiksen@dsm.com

Forward-looking statements

This press release contains forward-looking statements. These statements are based on current expectations, estimates and projections of DSM management and information currently available to the company. The statements involve certain risks and uncertainties that are difficult to predict and therefore DSM does not guarantee that its expectations will be realized. Furthermore, DSM has no obligation to update the statements contained in this press release.